| Evidence for network-based cortical thickness reductions in schizophrenia CMJ Wannan, VL Cropley, MM Chakravarty, C Bousman, EP Ganella, ... American Journal of Psychiatry 176 (7), 552-563, 2019 | 123 | 2019 |
| Structural neuroimaging across early-stage psychosis: Aberrations in neurobiological trajectories and implications for the staging model CF Bartholomeusz, VL Cropley, C Wannan, M Di Biase, PD McGorry, ... Australian & New Zealand Journal of Psychiatry 51 (5), 455-476, 2017 | 76 | 2017 |
| Neurological, neuropsychiatric and neurodevelopmental complications of COVID-19 C Pantelis, M Jayaram, AJ Hannan, R Wesselingh, J Nithianantharajah, ... Australian & New Zealand Journal of Psychiatry 55 (8), 750-762, 2021 | 57 | 2021 |
| Cognitive intervention in early psychosis—preserving abilities versus remediating deficits C Pantelis, C Wannan, CF Bartholomeusz, K Allott, PD McGorry Current Opinion in Behavioral Sciences 4, 63-72, 2015 | 44 | 2015 |
| Duration of untreated psychosis and neurocognitive functioning in first-episode psychosis: a systematic review and meta-analysis K Allott, D Fraguas, CF Bartholomeusz, CM Díaz-Caneja, C Wannan, ... Psychological medicine 48 (10), 1592-1607, 2018 | 36 | 2018 |
| Cognitive reserve attenuates age-related cognitive decline in the context of putatively accelerated brain ageing in schizophrenia-spectrum disorders TE Van Rheenen, V Cropley, B Fagerlund, C Wannan, J Bruggemann, ... Psychological Medicine 50 (9), 1475-1489, 2020 | 27 | 2020 |
| Deterioration of visuospatial associative memory following a first psychotic episode: a long-term follow-up study CMJ Wannan, CF Bartholomeusz, VL Cropley, TE Van Rheenen, ... Psychological medicine 48 (1), 132-141, 2018 | 27 | 2018 |
| Brain morphology is differentially impacted by peripheral cytokines in schizophrenia-spectrum disorder L Laskaris, S Mancuso, CS Weickert, A Zalesky, G Chana, C Wannan, ... Brain, Behavior, and Immunity 95, 299-309, 2021 | 22 | 2021 |
| Hippocampal subfields and visuospatial associative memory across stages of schizophrenia-spectrum disorder CMJ Wannan, VL Cropley, MM Chakravarty, TE Van Rheenen, ... Psychological Medicine 49 (14), 2452-2462, 2019 | 22 | 2019 |
| Risk and resilience brain networks in treatment-resistant schizophrenia EP Ganella, C Seguin, CF Bartholomeusz, S Whittle, C Bousman, ... Schizophrenia research 193, 284-292, 2018 | 20 | 2018 |
| Plasma neurofilament light chain protein is not increased in treatment-resistant schizophrenia and first-degree relatives D Eratne, S Janelidze, CB Malpas, S Loi, M Walterfang, A Merritt, I Diouf, ... Australian & New Zealand Journal of Psychiatry 56 (10), 1295-1305, 2022 | 17 | 2022 |
| An Interleukin-1 beta (IL1B) haplotype linked with psychosis transition is associated with IL1B gene expression and brain structure MS Mostaid, S Dimitrakopoulos, C Wannan, V Cropley, CS Weickert, ... Schizophrenia Research 204, 201-205, 2019 | 15 | 2019 |
| Plasma neurofilament light in behavioural variant frontotemporal dementia compared to mood and psychotic disorders D Eratne, M Kang, C Malpas, S Simpson-Yap, C Lewis, C Dang, J Grewal, ... Australian & New Zealand Journal of Psychiatry 58 (1), 70-81, 2024 | 13 | 2024 |
| A systematic review of cognition-brain morphology relationships on the schizophrenia-bipolar disorder spectrum JA Karantonis, SP Carruthers, SL Rossell, C Pantelis, M Hughes, ... Schizophrenia Bulletin 47 (6), 1557-1600, 2021 | 13 | 2021 |
| Cognitive behavioral markers of neurodevelopmental trajectories in rodents KHC Choy, JK Luo, CMJ Wannan, L Laskaris, A Merritt, WT Syeda, ... Translational Psychiatry 11 (1), 556, 2021 | 9 | 2021 |
| A sequential adaptive intervention strategy targeting remission and functional recovery in young people at ultrahigh risk of psychosis: The Staged Treatment in Early Psychosis … PD McGorry, C Mei, GP Amminger, HP Yuen, M Kerr, J Spark, N Wallis, ... JAMA psychiatry 80 (9), 875-885, 2023 | 8 | 2023 |
| Impaired olfactory ability associated with larger left hippocampus and rectus volumes at earliest stages of schizophrenia: A sign of neuroinflammation? Y Masaoka, D Velakoulis, WJ Brewer, VL Cropley, CF Bartholomeusz, ... Psychiatry Research 289, 112909, 2020 | 8 | 2020 |
| Cortico-cognition coupling in treatment resistant schizophrenia WT Syeda, CMJ Wannan, AH Merritt, JM Raghava, M Jayaram, ... NeuroImage: Clinical 35, 103064, 2022 | 5 | 2022 |
| Justification and implications of the introduction of an expanded C lose M arking S ystem for the F ellowship E xamination SW Beasley, C Wannan, N Hardware ANZ journal of surgery 83 (6), 444-447, 2013 | 5 | 2013 |
| Accelerating medicines partnership® Schizophrenia (AMP® SCZ): Rationale and study design of the largest global prospective cohort study of clinical high risk for psychosis CMJ Wannan, B Nelson, J Addington, K Allott, A Anticevic, C Arango, ... Schizophrenia bulletin 50 (3), 496-512, 2024 | 4 | 2024 |
